Clinical Trials Browser

OTHER × Observational × peginterferon alfa-2a × Clear all

NCT04943679 2022-03-31

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

Gastrointestinal

Carcinoma, Hepatocellular